Advancements in chemotherapy and immunotherapy have improved multiple myeloma survival rates, with 5-year relative survival increasing from 37.7% to 60.3% between 2000-2004 and 2015-2019. Treatment ...

A person diagnosed with dementia has improved survival outcomes in recent years amid significant progress in dementia diagnosis and care, according to a recent multinational study led by a University ...

RALEIGH, N.C. (WTVD) -- The American Cancer Society reports that the five-year relative cancer survival rate for all cancers combined hit 70% for people diagnosed between 2016-2021 in the United ...

BVd regimen showed significant OS improvement over DVd in relapsed/refractory multiple myeloma, with a predicted median OS of 84 months versus 51 months. BVd achieved higher ORR (83.1% vs 71.3%) and ...

Cancer stories, as we’ve long told them, tend to follow one of two arcs: diagnosis, then a brave fight against the disease resulting either in survival or death. But journalist Jonathan Gluck’s story ...

Adding teclistamab to daratumumab dramatically improved progression-free survival and overall survival vs standard-of-care (SOC) therapy in patients with relapsed or refractory multiple myeloma (RRMM) ...

Cancer statistics have reached new heights — in good and not-so-good ways. The American Cancer Society (ACS) released its annual report on cancer trends this week, showing for the first time that more ...